J Korean Med Assoc.  2011 Sep;54(9):935-940. 10.5124/jkma.2011.54.9.935.

Management of presbytinnitus

• Kim SC
• Choi JY

• KMID: 2191178
• DOI: http://doi.org/10.5124/jkma.2011.54.9.935

Abstract

As the population is aging, the prevalence of presbycusis is increasing proportionally. The prevalence of tinnitus, which usually accompanies presbycusis, is also growing. Presbytinnitus, defined as tinnitus which accompanies presbycusis, not only influences the individual's well-being and productivity but also causes communication problems, isolation, and social withdrawal. We now need to adopt more aggressive approaches to treating presbytinnitus in the elderly population, rather than giving them discouraging comments on the course of disease progression. Although the exact mechanisms of presbytinnitus have not been revealed and the specified therapeutic methods have not yet been established, an increasing number of studies using masking, retraining therapy, psychological therapy, and some medications have shown promising outcomes for the management of presbytinnitus. Therefore, appropriate treatment with multidisciplinary modalities should be provided for patients with presbytinnitus in order to reduce a growing social burden.

Keyword

Presbycusis; Tinnitus; Therapeutics

MeSH Terms

Aged
Aging
Disease Progression
Efficiency
Humans
Masks
Presbycusis
Prevalence
Tinnitus

Reference

1. Field GP. A manual of diseases of the ear. 1893. London: Bailliere, Tindall & Cox.

2. Pulec JL. Cochlear nerve section for intractable tinnitus. Ear Nose Throat J. 1995. 74:468470–476.

3. Eggermont JJ, Roberts LE. The neuroscience of tinnitus. Trends Neurosci. 2004. 27:676–682.

4. Cohen SM, Labadie RF, Haynes DS. Primary care approach to hearing loss: the hidden disability. Ear Nose Throat J. 2005. 84:2629–31. 44

5. Sismanis A, Stamm MA, Sobel M. Objective tinnitus in patients with atherosclerotic carotid artery disease. Am J Otol. 1994. 15:404–407.

6. Sismanis A. Tinnitus. Curr Neurol Neurosci Rep. 2001. 1:492–499.

7. Darlington CL, Smith PF. Drug treatments for tinnitus. Prog Brain Res. 2007. 166:249–262.

8. Lopez-Gonzalez MA, Esteban-Ortega F. Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation. Med Hypotheses. 2005. 65:349–352.

9. Lopez-Gonzalez MA, Santiago AM, Esteban-Ortega F. Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway. J Otolaryngol. 2007. 36:213–219.

10. Sziklai I, Szilvassy J, Szilvassy Z. Tinnitus control by dopamine agonist pramipexole in presbycusis patients: a randomized, placebo-controlled, double-blind study. Laryngoscope. 2011. 121:888–893.

11. Lipman RI, Lipman SP. Phase-shift treatment for predominant tone tinnitus. Otolaryngol Head Neck Surg. 2007. 136:763–768.

12. Hazell J. Tinnitus and disability with ageing: adaptation and management. Acta Otolaryngol Suppl. 1990. 476:202–208.

13. Zagolski O. Management of tinnitus in patients with presbycusis. Int Tinnitus J. 2006. 12:175–178.

14. Jastreboff PJ, Hazell JW. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol. 1993. 27:7–17.

15. Aazh H, Moore BC, Glasberg BR. Simplified form of tinnitus retraining therapy in adults: a retrospective study. BMC Ear Nose Throat Disord. 2008. 8:7.

16. Lechtenberg R, Shulman A. The neurologic implications of tinnitus. Arch Neurol. 1984. 41:718–721.

17. Sullivan MD, Katon W, Dobie R, Sakai C, Russo J, Harrop-Griffiths J. Disabling tinnitus. Association with affective disorder. Gen Hosp Psychiatry. 1988. 10:285–291.

18. Ross V, Echevarria KH, Robinson B. Geriatric tinnitus: causes, clinical treatment, and prevention. J Gerontol Nurs. 1991. 17:6–11.

19. Graham JM, Hazell JW. Electrical stimulation of the human cochlea using a transtympanic electrode. Br J Audiol. 1977. 11:59–62.

20. Portmann M, Cazals Y, Negrevergne M, Aran JM. Temporary tinnitus suppression in man through electrical stimulation of the cochlea. Acta Otolaryngol. 1979. 87:294–299.

21. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985. 1:1106–1107.

22. Hoffman RE, Hawkins KA, Gueorguieva R, Boutros NN, Rachid F, Carroll K, Krystal JH. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry. 2003. 60:49–56.

23. Soussi T, Otto SR. Effects of electrical brainstem stimulation on tinnitus. Acta Otolaryngol. 1994. 114:135–140.

24. Ruckenstein MJ, Hedgepeth C, Rafter KO, Montes ML, Bigelow DC. Tinnitus suppression in patients with cochlear implants. Otol Neurotol. 2001. 22:200–204.

25. Ito J, Sakakihara J. Tinnitus suppression by electrical stimulation of the cochlear wall and by cochlear implantation. Laryngoscope. 1994. 104(6 Pt 1):752–754.

26. Souliere CR Jr, Kileny PR, Zwolan TA, Kemink JL. Tinnitus suppression following cochlear implantation. A multifactorial investigation. Arch Otolaryngol Head Neck Surg. 1992. 118:1291–1297.

27. House JW, Brackmann DE. Tinnitus: surgical treatment. Ciba Found Symp. 1981. 85:204–216.

28. De Ridder D, Vanneste S, Adriaenssens I, Lee AP, Plazier M, Menovsky T, van der Loo E, Van de Heyning P, Moller A. Microvascular decompression for tinnitus: significant improvement for tinnitus intensity without improvement for distress. A 4-year limit. Neurosurgery. 2010. 66:656–660.

29. Møller AR. Is there a place for microvascular decompression? Acta Neurochir (Wien). 2005. 147:921–923.